Compare
ACV Auctions Inc. vs Xometry, Inc. vs XBP Global Holdings, Inc. vs Nutex Health Inc.
| Latest fiscal year | ACV Auctions Inc. ACVA | Xometry, Inc. XMTR | XBP Global Holdings, Inc. XBPLast annual report: year ended 2024-12-31 | Nutex Health Inc. NUTX |
|---|---|---|---|---|
| Year ended | 2025-12-31 | 2025-12-31 | 2024-12-31 | 2025-12-31 |
| Revenue | $759.61M | $686.63M | $872.69M | $875.26M |
| Revenue growth (YoY) | +19.2% | +25.9% | n/a | +82.4% |
| Gross margin | n/a | 39.1% | 21.6% | 50.8% |
| Operating margin | -8.3% | -6.6% | -12.1% | 31.5% |
| Net margin | -8.7% | -9.0% | -24.7% | 8.1% |
| Net income | -$66.14M | -$61.75M | -$215.15M | $70.79M |
| EPS (Diluted) | -$0.39 | n/a | $0.41 | $10.48 |
| Operating cash flow | $78.23M | $6.09M | $23.27M | $248.12M |
| Free cash flow | $69.13M | -$24.09M | $16.97M | $245.60M |
| Cash & equivalents | $271.50M | $15.00M | $11.63M | $185.57M |
| Total assets | $1.09B | $703.72M | $390.42M | $918.52M |
| Total liabilities | $655.93M | $426.98M | $1.85B | $495.09M |
| Shareholders' equity | $429.68M | $276.74M | -$1.46B | $423.44M |
| Return on year-end equity | -15.4% | -22.3% | n/a | 16.7% |
| Shares outstanding | n/a | n/a | 30.17M | 7.09M |
Revenue, most recent five fiscal years
| Fiscal year | ACV Auctions Inc. | Xometry, Inc. | XBP Global Holdings, Inc. | Nutex Health Inc. |
|---|---|---|---|---|
| Latest | $759.61M Ended 2025-12-31 | $686.63M Ended 2025-12-31 | $872.69M Ended 2024-12-31 | $875.26M Ended 2025-12-31 |
| 1 year earlier | $637.16M Ended 2024-12-31 | $545.53M Ended 2024-12-31 | n/a | $479.95M Ended 2024-12-31 |
| 2 years earlier | $481.23M Ended 2023-12-31 | $463.41M Ended 2023-12-31 | n/a | $247.65M Ended 2023-12-31 |
| 3 years earlier | $421.53M Ended 2022-12-31 | $380.92M Ended 2022-12-31 | n/a | $219.29M Ended 2022-12-31 |
| 4 years earlier | $358.44M Ended 2021-12-31 | $218.34M Ended 2021-12-31 | n/a | $331.53M Ended 2021-12-31 |